companydata.dkONCONOX ApS: Financial statements 2022
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.
- Profit/Loss
- -40,672 kr.
- Equity
- -4,305 kr.
- Total Assets
- 21,479 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -41 t. | -4 t. | - |
| 2021 | - | - | -44 t. | -43 t. | - |
| 2020 | - | - | -13 t. | 633 | - |
| 2019 | - | - | -66 t. | -37 t. | - |
| 2018 | - | 0 | -1 mio. | 29 t. | - |
Keep an eye on ONCONOX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ONCONOX ApS has published its annual report for 2021. The net result was DKK -43,846.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.